AstraZeneca has sought to reassure investors that its plans to replace traditional chemotherapy with a new generation of targeted drugs are on track, as it announced full trial results at a medical congress on Monday.
阿斯利康(AstraZeneca)試圖讓投資者放心，該公司用新一代靶向藥物取代傳統化療的計劃正在如期進行。該公司周一在一個醫學大會上公布了完整試驗結果。
您已閱讀6%（294字），剩余94%（4602字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。